GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spago Nanomedical AB (FRA:7UX) » Definitions » PB Ratio

Spago Nanomedical AB (FRA:7UX) PB Ratio : 1.38 (As of May. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Spago Nanomedical AB PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-23), Spago Nanomedical AB's share price is €0.018. Spago Nanomedical AB's Book Value per Share for the quarter that ended in Mar. 2024 was €0.01. Hence, Spago Nanomedical AB's PB Ratio of today is 1.38.

The historical rank and industry rank for Spago Nanomedical AB's PB Ratio or its related term are showing as below:

FRA:7UX' s PB Ratio Range Over the Past 10 Years
Min: 0.14   Med: 1.38   Max: 2.91
Current: 1.49

During the past 13 years, Spago Nanomedical AB's highest PB Ratio was 2.91. The lowest was 0.14. And the median was 1.38.

FRA:7UX's PB Ratio is ranked better than
70.07% of 1313 companies
in the Biotechnology industry
Industry Median: 2.54 vs FRA:7UX: 1.49

During the past 12 months, Spago Nanomedical AB's average Book Value Per Share Growth Rate was -92.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -66.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -45.20% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -21.50% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Spago Nanomedical AB was -2.70% per year. The lowest was -66.20% per year. And the median was -10.15% per year.

Back to Basics: PB Ratio


Spago Nanomedical AB PB Ratio Historical Data

The historical data trend for Spago Nanomedical AB's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spago Nanomedical AB PB Ratio Chart

Spago Nanomedical AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.79 0.27 1.61

Spago Nanomedical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.33 0.20 1.61 1.74

Competitive Comparison of Spago Nanomedical AB's PB Ratio

For the Biotechnology subindustry, Spago Nanomedical AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spago Nanomedical AB's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spago Nanomedical AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where Spago Nanomedical AB's PB Ratio falls into.



Spago Nanomedical AB PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Spago Nanomedical AB's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=0.018/0.013
=1.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Spago Nanomedical AB  (FRA:7UX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Spago Nanomedical AB PB Ratio Related Terms

Thank you for viewing the detailed overview of Spago Nanomedical AB's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Spago Nanomedical AB (FRA:7UX) Business Description

Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, SE-223 63
Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through previous detection of tumors and metastases. The Tumorad products focuses on the development of a completely new form of radionuclide therapy for tumor selective radiation therapy of cancer. The company development projects are based on a platform of polymeric materials with varoious properties for precise diagnosis and treatment of life threatening and debilitating diseases.

Spago Nanomedical AB (FRA:7UX) Headlines

No Headlines